The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes
Open accessAbstract
Background: Small cell lung cancer (SCLC) is a deadly, high grade neuroendocrine (NE) tumor without recognized morphologic heterogeneity. However, over 30 years ago we described a SCLC subtype with “variant” morphology which did not express some NE markers and exhibited more aggressive growth. Methods: To quantitate NE properties of SCLCs, we developed a 50-gene expression-based NE score that could be applied to human SCLC tumors and cell lines, and genetically engineered mouse (GEM) models. We identified high and low NE subtypes of SCLC in all of our sample types, and characterized their properties. Results: We found that 16% of human SCLC tumors and 10% of SCLC cell lines were of the low NE subtype, as well as cell lines from the GEM model. High NE SCLC lines grew as non-adherent floating aggregates or spheroids while Low NE lines had morphologic features of the variant subtype and grew as loosely attached cells. While the high NE subtype expressed one of the NE lineage master transcription factors ASCL1 or NEUROD1, together with NKX2-1, the entire range of NE markers, and lacked expression of the neuronal and NE repressor REST, the low NE subtype had lost expression of most NE markers, ASCL1, NEUROD1 and NKX2-1 and expressed REST. The low NE subtype had undergone epithelial mesenchymal transition (EMT) and had activated the Notch, Hippo and TGFβ pathways and MYC oncogene . Importantly, the high and low NE group of SCLC lines had similar gene expression profiles as their SCLC tumor counterparts. Conclusions: SCLC tumors and cell lines can exhibit distinct inter-tumor heterogeneity with respect to expression of NE features. Loss of NE expression results in major alterations in morphology, growth characteristics, and molecular properties. These findings have major clinical implications as the two subtypes are predicted to have very different responses to targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
Self-citationAmplification and expression of the c-myc oncogene in human lung cancer cell lines
Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1983) · Nature · doi:10.1038/306194a0 · Cited by 920
Self-citationSmall-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.87 · Cited by 904
Self-citation(1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80023-x · Cited by 900
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., & Minna, J. D. (1985) · Nature · doi:10.1038/318069a0 · Cited by 665
Self-citationMYB function in normal and cancer cells
Ramsay, R. G., & Gonda, T. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2439 · Cited by 617
Saunders, L. R., Bankovich, A. J., Anderson, W. C., Aujay, M. A., Bheddah, S., Black, K., Desai, R., Escarpe, P. A., Hampl, J., Laysang, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9459 · Cited by 600
Mollaoglu, G., Guthrie, M. R., Böhm, S., Brägelmann, J., Can, I., Ballieu, P. M., Marx, A., George, J., Heinen, C., Chalishazar, M. D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.005 · Cited by 588
Self-citationRudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Gardner, E. E., Lok, B. H., Schneeberger, V. E., Desmeules, P., Miles, L. A., Arnold, P. K., Ni, A., Khodos, I., de Stanchina, E., Nguyen, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.006 · Cited by 526
Borromeo, M. D., Savage, T. K., Kollipara, R. K., He, M., Augustyn, A., Osborne, J. K., Girard, L., Minna, J. D., Gazdar, A. F., Cobb, M. H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.081 · Cited by 503
Self-citationIntratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Lim, J. S., Ibaseta, A., Fischer, M. M., Cancilla, B., O’Young, G., Cristea, S., Luca, V. C., Yang, D., Jahchan, N. S., Hamard, C., et al. (2017) · Nature · doi:10.1038/nature22323 · Cited by 485
Notch signaling induces cell cycle arrest in small cell lung cancer cells.
Sriuranpong, V., Borges, M. W., Ravi, R. K., Arnold, D. R., Nelkin, B. D., Baylin, S. B., & Ball, D. W. (2001) · PubMed · Cited by 477
Gazdar, A. F., Carney, D. N., Nau, M. M., & Minna, J. D. (1985) · PubMed · Cited by 477
Self-citationBreast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?
Campbell, L. L., & Polyak, K. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4914 · Cited by 416
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H. B., Meuwissen, R., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.021 · Cited by 369
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Denny, S. K., Yang, D., Chuang, C.-H., Brady, J. J., Lim, J. S., Grüner, B. M., Chiou, S.-H., Schep, A. N., Baral, J., Hamard, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.052 · Cited by 368
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Fernandez-Cuesta, L., Peifer, M., Lu, X., Sun, R., Ozretić, L., Seidel, D., Zander, T., Leenders, F., George, J., Müller, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4518 · Cited by 317
NCI-navy medical oncology branch cell line data base
Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Carney, D., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630505 · Cited by 303
Self-citationCarney, D. N., Mitchell, J. B., & Kinsella, T. J. (1983) · PubMed · Cited by 287
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P. D., Lee, V., Tan, C., Sullivan, J. P., Larsen, J. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410419111 · Cited by 282
Self-citationNkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
Snyder, E. L., Watanabe, H., Magendantz, M., Hoersch, S., Chen, T. A., Wang, D. G., Crowley, D., Whittaker, C. A., Meyerson, M., Kimura, S., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.018 · Cited by 268
Gao, Z., Ure, K., Ding, P., Nashaat, M., Yuan, L., Ma, J., Hammer, R. E., & Hsieh, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1604-11.2011 · Cited by 251
Stewart, C. A., Tong, P., Cardnell, R. J., Sen, T., Li, L., Gay, C. M., Masrorpour, F., Fan, Y., Bara, R. O., Feng, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15338 · Cited by 227
Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
Sato, M., Larsen, J. E., Lee, W., Sun, H., Shames, D. S., Dalvi, M. P., Ramirez, R. D., Tang, H., DiMaio, J. M., Gao, B., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0634-t · Cited by 205
Self-citationRosenbaum, J. N., Guo, Z., Baus, R. M., Werner, H., Rehrauer, W. M., & Lloyd, R. V. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpgzwxxbsnl4vd · Cited by 196
Swarts, D. R. A., Ramaekers, F. C. S., & Speel, E.-J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.001 · Cited by 179
Yamaguchi, T., Hosono, Y., Yanagisawa, K., & Takahashi, T. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.002 · Cited by 159
An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
Girard, L., Rodriguez-Canales, J., Behrens, C., Thompson, D. M., Botros, I. W., Tang, H., Xie, Y., Rekhtman, N., Travis, W. D., Wistuba, I. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2900 · Cited by 154
Self-citationPathology and Diagnosis of Neuroendocrine Tumors
Travis, W. D. (2014) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2014.04.001 · Cited by 152
Erratum: Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.106 · Cited by 149
Self-citationCharacterization of three new variant type cell lines derived from small cell carcinoma of the lung
de Leij, L., Postmus, P. E., Buys, C. H. C. M., Elema, J. D., Ramaekers, F. C. S., Poppema, S., Brouwer, M., van der Veen, A. Y., Mesander, G., & THE, T. H. (1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80707-3 · Cited by 143
Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
Poirier, J. T., Dobromilskaya, I., Moriarty, W. F., Peacock, C. D., Hann, C. L., & Rudin, C. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt130 · Cited by 133
YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer
Horie, M., Saito, A., Ohshima, M., Suzuki, H. I., & Nagase, T. (2016) · Cancer Science · doi:10.1111/cas.13078 · Cited by 120
Shimizu, E., Coxon, A. B., Otterson, G. A., Steinberg, S. M., Kratzke, R. A., Kim, Y. W., FEDORKO, J., Oie, H. K., Johnson, B. E., & Mulshine, J. L. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96300-k · Cited by 119
Expression of the c-myb oncogene in human small cell lung carcinoma.
Griffin, C. A., & Baylin, S. B. (1985) · PubMed · Cited by 114
Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β‐cell function
Jia, S., Ivanov, A., Blasevic, D., Müller, T. H., Purfürst, B., Sun, W., Chen, W., Poy, M. N., Rajewsky, N., & Birchmeier, C. (2015) · The EMBO Journal · doi:10.15252/embj.201490819 · Cited by 112
EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
Murai, F., Koinuma, D., Shinozaki‐Ushiku, A., Fukayama, M., Miyaozono, K., & Ehata, S. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.26 · Cited by 111
Loss of YAP 1 defines neuroendocrine differentiation of lung tumors
Ito, T., Matsubara, D., Tanaka, I., Makiya, K., Tanei, Z., Kumagai, Y., Shiu, S., Nakaoka, H. J., Ishikawa, S., Isagawa, T., et al. (2016) · Cancer Science · doi:10.1111/cas.13013 · Cited by 103
Chen, H., Yu, S., Ho, B., Su, K., Hsu, Y., Chang, C.-S., Li, Y.-C., Yang, S., Hsu, P.-Y., Ho, H. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.3590 · Cited by 98
Monaghan, C. E., Nechiporuk, T., Jeng, S., McWeeney, S. K., Wang, J., Rosenfeld, M. G., & Mandel, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620230114 · Cited by 94
Cardnell, R. J., Li, L., Sen, T., Bara, R. O., Tong, P., Fujimoto, J., Ireland, A. S., Guthrie, M. R., Bheddah, S., Banerjee, U., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20621 · Cited by 91
Self-citationHubaux, R., Thu, K. L., Coe, B. P., MacAulay, C. E., Lam, S. C., & Lam, W. L. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318298762f · Cited by 88
Udyavar, A. R., Wooten, D. J., Hoeksema, M., Bansal, M., Califano, A., Estrada, L., Schnell, S. D., Irish, J. M., Massion, P. P., & Quaranta, V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1467 · Cited by 83
Transcriptional control of vertebrate neurogenesis by the proneural factor Ascl1
Vasconcelos, F. F., & Castro, D. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00412 · Cited by 82
v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.
Mabry, M., Nakagawa, T., Nelkin, B. D., McDowell, E. M., Gesell, M. S., Eggleston, J., Casero, R. A., & Baylin, S. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6523 · Cited by 72
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
Gazdar, A. F., Hirsch, F. R., & Minna, J. D. (2015) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.009 · Cited by 66
Self-citationThiel, G., Ekici, M., & Rößler, O. G. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1963-0 · Cited by 60
Doyle, L. A. (1990) · Lung Cancer · doi:10.1016/0169-5002(90)90169-m · Cited by 57
Jacob, J., Storm, R., Castro, D. S., Milton, C. I., Pla, P., Guillemot, F., Birchmeier, C., & Briscoe, J. (2009) · Development · doi:10.1242/dev.034546 · Cited by 56
Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1
Jia, S., Wildner, H., & Birchmeier, C. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.10.009 · Cited by 55
NCI series of cell lines: An historical perspective
Gazdar, A. F., & Minna, J. D. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630502 · Cited by 55
Self-citationRosenbaum, J. N., Duggan, A., & García-Añoveros, J. (2011) · Neural Development · doi:10.1186/1749-8104-6-6 · Cited by 46
MYB-fusions and other potential actionable targets in adenoid cystic carcinoma
Ferrarotto, R., Heymach, J. V., & Glisson, B. S. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000280 · Cited by 41
Bex1 is involved in the regeneration of axons after injury
Khazaei, M. R., Halfter, H., Karimzadeh, F., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06960.x · Cited by 38
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer
Roche, J., Gemmill, R. M., & Drabkin, H. A. (2017) · Cancers · doi:10.3390/cancers9070072 · Cited by 36
Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma
Hu, X., Chen, L., Wang, Q., Zhao, X., Tan, J., Cui, Y., Liu, X., Zhang, X., & Bian, X. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203025 · Cited by 29
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
(1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80709-7 · Cited by 28
Ascl2 Reinforces Intestinal Stem Cell Identity
Yan, K. S., & Kuo, C. J. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.014 · Cited by 21
Ascl2 and 11p15.5 amplification in colorectal cancer
Jubb, A. M., Hoeflich, K. P., Haverty, P. M., Wang, J., & Koeppen, H. (2010) · Gut · doi:10.1136/gut.2010.231746 · Cited by 21
Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.
Xu, H., Zhao, X., Liu, X., Hu, X., Fu, W., Li, Q., Wang, Y., Ping, Y., Zhang, X., Bian, X., et al. (2017) · PubMed Central · Cited by 18
YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment
Pan, D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2093 · Cited by 13
Cited by
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Rudin, C. M., Poirier, J. T., Byers, L. A., Dive, C., Dowlati, A., George, J., Heymach, J. V., Johnson, J. E., Lehman, J. M., MacPherson, D., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0133-9 · Cited by 1,254
Self-citationGay, C. M., Stewart, C. A., Park, E. M., Diao, L., Groves, S. M., Heeke, S., Nabet, B. Y., Fujimoto, J., Solis, L. M., Lu, W., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.014 · Cited by 962
Self-citationBaine, M. K., Hsieh, M.-S., Lai, W. V., Egger, J. V., Jungbluth, A. A., Daneshbod, Y., Beras, A., Spencer, R., Lopardo, J., Bodd, F., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.09.009 · Cited by 522
Ireland, A. S., Micinski, A. M., Kastner, D. W., Guo, B., Wait, S. J., Spainhower, K. B., Conley, C. C., Chen, O. S., Guthrie, M. R., Soltero, D., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.001 · Cited by 508
Self-citationMegyesfalvi, Z., Gay, C. M., Popper, H., Pirker, R., Ostoros, G., Heeke, S., Lang, C., Hoetzenecker, K., Schwendenwein, A., Boettiger, K., et al. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21785 · Cited by 369
Metadata
- Authors
- Zhang, W., Girard, L., Zhang, Y.-A., Haruki, T., Papari-Zareei, M., Stastny, V., Ghayee, H. K., Pacak, K., Oliver, T. G., Minna, J. D., & Gazdar, A. F.
- Venue
- Translational Lung Cancer Research
- Publisher
- AME Publishing Company
- Published
- 2018-02
- Volume
- 7
- Issue
- 1
- Pages
- 32-49
- ISSN
- 2218-6751 (ISSN-L)
- 2226-4477
- OpenAlex
- W2786927525
- Cited by
- 263
- References
- 65
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.